Back to search
FDAFDA · Food and drugs·Recall number D-1306-2020

Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy Distributed by Roerig Division of Pfizer Inc. New York, NY 10017 vial NDC 0049-0013-81, carton NDC 0049-0013-83

Published June 17, 2020 · Recall initiated: May 29, 2020

Summary

FDA records drug Class II recall D-1306-2020, published June 17, 2020 and initiated May 29, 2020. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 94320 units; Lot: Lot # 3301612, EXP 02/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: particulate matter identified after reconstitution.

What to do

Voluntary: Firm initiated · Letter

Get an email if UNASYN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
UNASYN
Manufacturer
Pfizer Inc.
Distributor
Distributed Nationwide in the US
Lot
Lot # 3301612, EXP 02/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy Distributed by Roerig Division of Pfizer Inc. New York, NY 10017 vial NDC 0049-0013-81, carton NDC 0049-0013-83 recalled?

Yes. FDA published recall D-1306-2020 on June 17, 2020. Reported hazard: Presence of Particulate Matter: particulate matter identified after reconstitution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: UNASYN.